Vironix remote physiological monitoring & disease-specific AI intelligence for respiratory and cardiovascular chronic illnesses
Our Motivation
Either you or someone you know has been impacted by heart or lung disease.
17.9 MILLION PEOPLE
die each year from cardiovascular disease.
That’s one death every 56 seconds.
People diagnosed with or at risk of heart failure, COPD, asthma, & acute respiratory illness face constant risk of death, hospitalization, massive healthcare expenditures, and persistent anxiety. If detected and managed early, singular health deterioration episodes, which include exacerbations & infections, can be readily addressed at home with diet, medications, and rest.
$400 BILLION
is the cost of preventable heart and lung disease to employers and health insurance providers
Peer-Reviewed, World Class R&D
Clinically validated algorithms built by scientists and clinicians.
Recent News
CURE Medical Center to Add Vironix AI-Preventative Care Technology to Chronic & Concierge Care Services
2023-04-02
CURE / Malibu Medical Group is utilizing Vironix Health’s AI-Enabled Remote Patient Care Products to improve chronic disease management and promote preventative care in Southern California.
Vironix Health was selected to present at Innov8 Talks
2023-04-02
Congratulations to the Vironix Health team members - Sumanth Swaminathan Botros Toro Ram Reddy and Jeff Hanson, MPH who presented their pitch at the 2023 Arab Health Exhibition - Innov8 Talks. Bravo! Our team was very excited to be part of this year’s event in Dubai. We look forward to attending next year as well.
About Vironix
Vironix was formed by passionate scientists, physicians, technologists, and entrepreneurs who have amassed decades of research, development, and commercialization expertise in the development, testing, and commercialization of medical technology.